Drug Makers / Doctors/ Hospitals Definite Beneficiaries of Obamacare

Well, it’s hardly a surprise, given the way the TBTF banks have “cleaned up” under Obama,

but it’s apparently already clear that at least THREE major beneficiaries of Obamacare will be hospitals and pharmaceutical companies,

[br]

Well, it’s hardly a surprise, given the way the TBTF banks have “cleaned up” under Obama,

but it’s apparently already clear that at least THREE major beneficiaries of Obamacare will be hospitals and pharmaceutical companies,

[br]

Well, it’s hardly a surprise, given the way the TBTF banks have “cleaned up” under Obama,

but it’s apparently already clear that at least THREE major beneficiaries of Obamacare will be hospitals and pharmaceutical companies,

[br]

the latter of whom apparently spent quite a bit of money in advertising support for the bill.

Apparently, so will doctors, altho seemingly not as immediately as the former ;-), and my own view is that insurance companies will as well,

since there is a significant insurance “mandate” – and plenty of Federal money to make sure people DO sign up –

but they spent HUGE amounts of money FIGHTING the bill, or, at least, the alleged “public option” that they, among others, successfully defeated.

Some choice excerpts from this New York Times article:

[quote]

For anyone assessing the impact, it is important to remember that few of the legislation’s main provisions would take place immediately, noted Jason Gurda, an analyst with Leerink Swann.

“Most of the health care provisions that would impact the health insurers do not kick in until 2014,” he said. “From an investment horizon, that’s a long time.”…

Hospitals have little to fear. The number of newly insured is expected to decrease significantly the amount that hospitals now lose each year when they provide care to people with no means to pay …

Doctors are another group likely to benefit from more paying customers, which is a reason that the American Medical Association last week began publicly supporting the legislation….

Drug makers, meanwhile, may have the most clear reason to celebrate the legislation.

Pharmaceutical companies are going to be asked to contribute $85 billion toward the cost of the bill in the form of industry fees and lower prices paid under government programs over 10 years.

But they can look forward to tens of billions of dollars in additional revenue as more people with insurance visit doctors and fill prescriptions.

[/quote]